Characterizing type 2 diabetes (T2D) subtypes in the U.S. to improve prevention, diagnosis, treatment, and management
Definition, Etiology, Function: INtegration to Enhance Type 2 Diabetes treatment (DEFINE-T2D) Consortium
In 2024, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) funded the DEFINE-T2D consortium to better understand heterogeneity in T2D. Leveraging data on clinical, genetics, omics, environmental exposures, lifestyle behaviors, and social factors, major goals of DEFINE-T2D are to: 1) develop a broadly applicable framework for identifying subtypes of T2D; and 2) increase understanding of the physiologic drivers of T2D subtypes to guide development of more effective precision interventions
Get to know who is behind the science! The Investigator and Staff Spotlight series celebrates the stories, interests, and expertise of the DEFINE-T2D community by showcasing the people behind impactful discovery and innovation in diabetes research.
DEFINE-T2D In-Person Meeting
|
All Day
New Orleans Marriott Warehouse Arts District
859 Convention Center Blvd. New Orleans, LA 70130
859 Convention Center Blvd. New Orleans, LA 70130
Add event to:
DEFINE-T2D In-Person Meeting
|
All Day
Add event to:
CMS Login